Koch C - Search Results

1

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.

Frederiksen B, Koch C, Høiby N. Frederiksen B, et al. Among authors: koch c. Pediatr Pulmonol. 1997 May;23(5):330-5. doi: 10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o. Pediatr Pulmonol. 1997. PMID: 9168506 Clinical Trial.

2

Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis.

Hodson ME, McKenzie S, Harms HK, Koch C, Mastella G, Navarro J, Strandvik B; Investigators of the Epidemiologic Registry of Cystic Fibrosis. Hodson ME, et al. Among authors: koch c. Pediatr Pulmonol. 2003 Nov;36(5):427-32. doi: 10.1002/ppul.10348. Pediatr Pulmonol. 2003. PMID: 14520726

3

Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.

Shori DK, Genter T, Hansen J, Koch C, Wyatt H, Kariyawasam HH, Knight RA, Hodson ME, Kalogeridis A, Tsanakas I. Shori DK, et al. Among authors: koch c. Pflugers Arch. 2001;443 Suppl 1:S55-61. doi: 10.1007/s004240100645. Epub 2001 Sep 28. Pflugers Arch. 2001. PMID: 11845304

4

Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.

Main KM, Skov M, Sillesen IB, Dige-Petersen H, Müller J, Koch C, Lanng S. Main KM, et al. Among authors: koch c. Acta Paediatr. 2002;91(9):1008-11. doi: 10.1080/080352502760272759. Acta Paediatr. 2002. PMID: 12412882

5

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG. Mastella G, et al. Among authors: koch c. Eur Respir J. 2000 Sep;16(3):464-71. doi: 10.1034/j.1399-3003.2000.016003464.x. Eur Respir J. 2000. PMID: 11028661 Free article.

6

Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.

Kronborg G, Pressler T, Fomsgaard A, Koch C, Høiby N. Kronborg G, et al. Among authors: koch c. Infection. 1993 Sep-Oct;21(5):297-302. doi: 10.1007/BF01712448. Infection. 1993. PMID: 8300245

7

Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.

Hartling SG, Garne S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C. Hartling SG, et al. Among authors: koch c. Diabetes Res. 1988 Apr;7(4):165-9. Diabetes Res. 1988. PMID: 3042255

8

Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis.

Schønheyder H, Jensen T, Laessøe IH, Høiby N, Koch C. Schønheyder H, et al. Among authors: koch c. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):40-4. doi: 10.1007/BF01962169. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3132374

9

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.

Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, Strandvik B, McKenzie SG. Navarro J, et al. Among authors: koch c. Eur Respir J. 2001 Aug;18(2):298-305. doi: 10.1183/09031936.01.00068901. Eur Respir J. 2001. PMID: 11529288 Free article.

10

Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.

Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N, Koch C. Pressler T, et al. Among authors: koch c. Pediatr Pulmonol. 1994 Jan;17(1):31-40. doi: 10.1002/ppul.1950170107. Pediatr Pulmonol. 1994. PMID: 8108174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results